Shuji Hibiya, Kento Takenaka, Ryuichi Okamoto. Comparison of the efficacy of biologics for intestinal stricture in Crohn's disease. 第107回日本消化器内視鏡学会総会 2024.05.31 国際館パミール
Ami Kawamoto, Kento Takenaka, Ryuichi Okamoto. Efficacy of biomarkers in predicting prognosis of Crohn’s disease patients with small bowel disease. 第107回日本消化器内視鏡学会総会 2024.05.30 国際館パミール
K Matsuoka, S Motoya, T Yamamoto, M Matsuura, T Fujii, S Shinzaki, Y Mikami, S Arai, J Oshima, Y Endo, H Yuasa, M Hoshi, K Sato, T Hisamatsu. Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data. DDW2024 米国消化器病学会 2024.05.19 Walter E. Washington Convention Center_ Washington, D.C.
Hiroshi Nakase, Toshimitsu Fujii, Tadakazu Hisamatsu, Yasuo Suzuki, Mamoru Watanabe, Yoko Uchikawa, Shoichiro Goto, Go Fujimoto, Changliang Zhang, Toshifumi Hibi. Ozanimod as induction and maintenance therapy for ulcerative colitis: a randomized, double-blind, placebo-controlled study in Japan (J-True North). DDW2024 米国消化器病学会 2024.05.19 Walter E. Washington Convention Center_ Washington, D.C.
Katsuyoshi Matsuoka, Satoshi Motoya, Takayuki Yamamoto, Minoru Matsuura, Toshimitsu Fujii, Shinichiro Shinzaki, Yohei Mikami, Shoko Arai, Junichi Oshima, Yutaka Endo, Hirotoshi Yuasa, Masato Hoshi, Keiko Sato, Tadakazu Hisamatsu. Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of effectiveness and safety data. 19th Congress of ECCO 2024.02.23 Stockholmsmässan_Stockholm
N.Takatsu, T.Yamamoto, H.Nakase, S.Shinzaki, K.Watanabe, T.Fujii, R.Okamoto, K.Matsuoka, A.Yamada, R.Kunisaki, M.Matsuura, H.Shiga, S.Bamba, Y.Mikami, T.Shimoyama, S.Motoya, T.Torisu, T.Kobayashi, N.Ohmiya, M.Saruta, S.Yoshigoe, Y.Murata, T.Hisamatsu. Clinical features and surgical necessity rate of fistulisingperianal disease in newly diagnosed patients with Crohn's disease: Interim analysis of inception cohort registry study of patients with Crohn's disease (iCREST-CD). 19th Congress of ECCO 2024.02.23 Stockholmsmässan_Stockholm
Katsuyoshi Matsuoka, Hiroshi Nakase, Toshimitsu Fujii, Tadakazu Hisamatsu, Yasuo Suzuki, Mamoru Watanabe, Yoko Uchikawa, Shoichiro Goto, Go Fujimoto, Changliang Zhang, Toshifumi Hibi. Ozanimod as a once-daily oral therapy for Japanese patients with ulcerative colitis: results from the induction period of a phase 2/3 study (J-True North). 19th Congress of ECCO 2024.02.23 Stockholmsmässan_Stockholm
Kento Takenaka. Deep neural network for video colonoscopy of ulcerative colitis. JDDW2023 2023.11.04 Kobe_Japan
Marla C. Dubinsky, Geert D’Haens, Olivier Dewit, Pascal Juillerat, Remo Panaccione, Toshimitsu Fujii, Ana P Lacerda, Elena Dubcenco, Samuel Anyanwu, Chirag Doshi, John Liu, Andrew Garrison, Edward V Loftus Jr. Corticosteroid-Sparing Effect of Upadacitinib in Patients With Moderately to Severely Active Crohn’s Disease. ACG 2023 - American College of Gastroenterology 2023.10.20 Vancouver_Canada
B.Bressler, L.Peyrin-Biroulet, J.R.Allegretti, K.G.Huang, M.Germinaro, N.Shipitofsky, Y.Miao, H.Zhang, M.Bortlik, T.Hlavaty, T.Fujii, B.G.Feagan, B.E.Sands, A.Dignass on behalf of the QUASAR Investigators. The Efficacy of Induction Treatment With Guselkumab in Patients with Moderately to Severely Active Ulcerative Colitis: Phase 3 QUASAR Induction Study Results at Week 12 by Prior Advanced Therapy History. ACG 2023 - American College of Gastroenterology 2023.10.20 Vancouver_Canada
T. Fujii , S. Hibiya , H. Shimizu , A. Kawamoto , K. Takenaka , E. Saito , M. Nagahori , K. Ohtsuka , R. Okamoto. DUAL THERAPY WITH CAROTEGRAST (AJM300: ORAL α4 INTEGRIN ANTAGONIST) AND BIOLOGICS FOR REFRACTORY ULCERATIVE COLITIS. UEGW2023 2023.10.15 Copenhagen_Denmark
Minhu Chen, Xiang Gao, Kenji Watanabe, Toshimitsu Fujii, Jae Hee Cheon, Shu-Chen Wei, Dennis Teng, Ana P Lacerda, Valencia P Remple, Hiroshi Nakase. Efficacy of Induction Upadacitinib Therapy in East Asian Patients With Moderately to Severely Active Crohn’s Disease. UEGW2023 2023.10.15 Copenhagen_Denmark
B.Bressler, L.Peyrin-Biroulet, J.R.Allegretti, K.G.Huang, M.Germinaro, N.Shipitofsky, Y.Miao, H.Zhang, M.Bortlik, T.Hlavaty, T.Fujii, B.G.Feagan, B.E.Sands, A.Dignass on behalf of the QUASAR Investigators. The Efficacy of Induction Treatment With Guselkumab in Patients with Moderately to Severely Active Ulcerative Colitis: Phase 3 QUASAR Induction Study Results at Week 12 by Prior Advanced Therapy History. UEGW2023 2023.10.15 Copenhagen_Denmark
A. Kawamoto, K. Takenaka, S. Hibiya, Y. Kitazume, K. Ito, H. Shimizu, T. Fujii, E. Saito, K. Ohtsuka, R. Okamoto. COMBINING LEUCINE-RICH ALPHA-2 GLYCOPROTEIN AND FAECAL BIOMARKERS FOR ACCURATE MONITORING OF SMALL BOWEL ACTIVITY IN CROHN’S DISEASE. UEGW2023 2023.10.14 Copenhagen_Denmark
Shuij Hibiya, Takashi Fujii, Toshimitsu Fujii, Kazuo Ohtsuka, Ryuichi Okamoto. Severe COVID-19 is associated with risk of lower gastrointestinal bleeding. UEGW2023 2023.10.14 Copenhagen_Denmark
Marc Ferrante, Laurent Peyrin-Biroulet, Axel Dignass, David T. Rubin, Silvio Danese, Geert D'Haens, Kristina Kligys, Sofie Berg, Jasmina Kalabic, Javier Zambrano, Yafei Zhang, Toshimitsu Fujii, and Remo Panaccione. Clinical and Endoscopic Improvements with Risankizumab Induction and Maintenance Dosing Versus Placebo are Observed Irrespective of Number of Prior Failed Biologics. UEGW2023 2023.10.11 Copenhagen_Denmark
Marla C. Dubinsky, Geert D’Haens, Olivier Dewit, Pascal Juillerat, Remo Panaccione, Toshimitsu Fujii, Ana P Lacerda, Elena Dubcenco, Samuel Anyanwu, Chirag Doshi, Madhuja Mallick, Andrew Garrison, John Liu, Edward V Loftus Jr. Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn’s disease treated with upadacitinib. SGG Swiss congress 2023 2023.09.23 Interlaken_Switzerland
Marla C. Dubinsky, Geert D’Haens, Olivier Dewit, Pascal Juillerat, Remo Panaccione, Toshimitsu Fujii, Ana P Lacerda, Elena Dubcenco, Samuel Anyanwu, Chirag Doshi, Madhuja Mallick, Andrew Garrison, John Liu, Lena Thin, Edward V Loftus Jr. Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn’s disease treated with upadacitinib. AGW2023 2023.09.02 Brisbane_Australia
Kazuo Ohtsuka, Kento Takenaka, Ryuichi Okamoto. Cutting-edge of clinical practice in SBE. The 105th Congress of the Japan Gastroenterological Endoscopy Society 2023.05.26 Tokyo_Japan
Marla C. Dubinsky, Geert D’Haens, Olivier Dewit, Pascal Juillerat, Remo Panaccione, Toshimitsu Fujii, Ana P. Lacerda, Elena Dubcenco, Samuel Anyanwu, Chirag Doshi, Madhuja Mallick, Andrew Garrison, John Liu, Edward V. Loftus Jr. Corticosteroid Discontinuation and Clinical Outcomes in Patients With Moderately to Severely Active Crohn’s Disease Treated With Upadacitinib. DDW2023 2023.05.09 Washington,D.C._USA
Marc Ferrante, Qian Cao, Toshimitsu Fujii, Astrid Rausch, Ezequiel Neimark, Alexandra Song, Kori Wallace, Kristina Kligys, Qing Zhou, Jasmina Kalabic, Brian Feagan. Patients with Moderate-to-Severe Crohn’s Disease with and without Prior Biologic Failure Demonstrate Improved Endoscopic Outcomes with Risankizumab: Results from Phase 3 Induction and Maintenance Trials Marc. DDW2023 2023.05.09 Washington,D.C._USA
M.C. Dubinsky, G. D’Haens, O. Dewit, P. Juillerat, R. Panaccione, T. Fujii, A.P. Lacerda, E. Dubcenco, S.Anyanwu, C. Doshi, M. Mallick, A. Garrison, J. Liu, E.V. Loftus Jr.. Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn's disease treated with upadacitinib. 18th Congress of ECCO 2023.03.02 Copenhagen_Denmark
Marc Ferrante, Laurent Peyrin-Biroulet, Axel Dignass, David T. Rubin, Silvio Danese, Geert D'Haens, Kristina Kligys, Sofie Berg, Jasmina Kalabic, Javier Zambrano, Yafei Zhang, Toshimitsu Fujii, and Remo Panaccione. Clinical and Endoscopic Improvements with Risankizumab Induction and Maintenance Dosing Versus Placebo are Observed Irrespective of Number of Prior Failed Biologics. American College of Gastroenterology Annual Scientific Meeting 2022.10.25
B.Feagan,J.F.Colombel,J.Torres,T.Fujii,W.Zhou,X.Yao,Y.Sanchez Gonzalez,D.Ilo,X.Roblin. IMPACT OF INFLAMMATORY BURDEN ON EFFICACY OF UPADACITINIB MAINTENANCE THERAPY IN ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 U-ACHIEVE STUDY. UEGW2022 2022.10.11
M Ferrante, Q Cao, T Fujii, A Rausch, E Neimark, A Song, K Wallace, K Kligys, Q Zhou, J Kalabic, B G Feagan. Patients with moderate to severe Crohn’s Disease with and without prior biologic failure demonstrate improved endoscopic outcomes with risankizumab: Results from phase 3 induction and maintenance trials. ECCO2022 2022.02.18
Kento Takenaka, Kazuo Ohtsuka, Ryuichi Okamoto. Balloon assisted enteroscopy and Magnetic resonance enterograpy for Small bowel Crohn’s disease. JDDW2021 2021.11.06 神戸コンベンションセンター
Kent Tkenaka. Higher Concentrations of TNF antibodies are associated with better healing of the small bowel in crohn's disease. JDDW2021 2021.11.05 神戸コンベンションセンター(兵庫)
土屋輝一郎、長堀正和、日比谷秀爾、竹中健人、河本亜美、清水寛路、藤井俊光、齊藤詠子、大塚和朗、渡辺 守、岡本隆一 . 【誌面発表】COVID-19蔓延下におけるスマートデバイスを用いたIBD病診連携に関する研究. 厚生労働科学研究費 難治性疾患政策研究事業 「難治性炎症性腸管障害に関する調査研究」令和3年度 第1回総会 2021.07.15 Web開催
Kento Takenaka. Deep Neural Network for Accurate Evaluation of Endoscopic Images from Patients with Ulcerative Colitis. IMKASID 2021 2021.04.16 Online
Toshimitsu Fujii, Shuji Hibiya, Chiaki Maeyashiki, Eiko Saito, Kento Takenaka, Maiko Motobayashi, Hiromichi Shimizu, Masakazu Nagahori, Kazuo Ohtsuka, Masayuki Kurosaki, Tsunehito Yauchi, Mamoru Watanabe. Intolerance to 5-aminosalicylate is a risk of poor prognosis in Ulcerative colitis patients.. ECCO2020 2020.02.14 Vienna(Austria)
Naoya Tsugawa, Takashi Nagaishi, Daiki Yamada, Toshimitsu Fujii, Yudai Kojima, Arisa Tokai, Taro Watabe, Shuang Wang, Michio Onizawa, Takahiro Adachi, Mamoru Watanabe. BCR signaling in the activated B cells may be regulated by the long isoform of Ceacam1. 第48回日本免疫学会学術集会 2019.12.11 アクトシティ浜松
Kento Takenaka, Kazuo Ohtsuka, Toshimitsu Fujii, Kohei Suzuki, Hiromichi Shimizu, Maiko Motobayashi, Shuji Hibiya, Eiko Saito, Masakazu Nagahori, Mamoru Watanabe. Small bowel endoscopic healing of Crohn’s disease treated with anti-TNF antibodies. AOCC2019 2019.06.15 Taipei(Taiwan)
Eiko Saito, Kohei Suzuki, Shuuji Hibiya, Maiko Motobayashi, Kento Takenaka, Nobukatsu Horita, Hiromichi Shimizu, Michio Onizawa, Toshimitsu Fujii, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe. The clinical efficacy of ustekinumab (UST) in patients with Crohn’s disease (CD). AOCC2019 2019.06.15 台北
齊藤詠子、秋山慎太郎、鈴木康平、本林麻衣子、竹中健人、清水寛路、鬼澤道夫、藤井俊光、長堀正和、大塚和朗、渡辺 守. クローン病における抗TNF-α抗体二次無効時のウステキヌマブの治療成績について. 第9回日本炎症性腸疾患学会学術集会 2018.11.22 メルパルク京都(京都府京都市)
Takenaka K, Ohtsuka K, Fujii T, Nagahori M, Saito E, Motobayashi M, Suzuki K, Watanabe M. Small bowel mucosal healing of Crohn’s disease treated with anti-TNF antibodies. FALKsymposium 2018.09.07 Kyoto(JAPAN)
Saito E, Suzuki K, Shimizu H, Motobayashi M, Takenaka K, Onizawa M, Fujii T, Nagahori M, Ohtsuka K, Watanabe M. The clinical efficacy of switching cases between Infliximab(IFX) andAdalimumab(ADA) in patients with ulcerative colitis. AOCC2018 2018.06.22 Shanghai
Ohtsuka K, Takenaka K, Suzuki K, Fujii T, Nagahori M, Matsuoka K, Saito E, Katsukura N, Fukuda M, Araki A, Watanabe M. Usefulness of single-balloon enteroscopy: from a single center 990 experiences. DDW2018 2018.06.03 Washington D.C (USA)
Fujii T, Kitazume Y, Takenaka K, Kimura M, Saito E, Matsuoka K, Nagahori M, Ohtsuka K, Watanabe M. Simplified MR enterocolonography Classification Based on Endoscopic Findings for Activity Assessment of Crohn’s Disease. UEGW2017 2017.11.01 Barcelona(Spain)
Shinzaki S, Fujii T, Bamba S, Kobayashi T, Tanaka T, Yoshino T, Yamada A, Kamata N, Hibi T. Safety and efficacy of Helicobacter pylori eradication in patients with inflammatory bowel disease. UEGW2017 2017.10.31 Barcelona(Spain)
Tanaka H, Kamata N, Yamada A, Fujii T, Endo K, Yoshino T, Bamba S, Sugaya T, Kawaguchi T, Ishii M, Shinzaki S, Toya Y, Yanai Y, Yokoyama Y, Umeno J, Okada T, Kobayashi T, Nojima M, Hibi T. Usefulness of combination therapy with adalimumab and immunomodulators in patients with crohn’s disease: a large, multi-centre cohort study. UEGW2017 2017.10.31 Barcelona(Spain)
Takenaka K, Ohtsuka K, Kitazume Y, Fujii T, Matsuoka K, Kimura M, Nagahori M, Watanabe M. Utility of Magnetic Resonance Evaluation for Small Bowel Endoscopic Healing in Patients with Crohn’s Disease. UEGW2017 2017.10.30 Barcelona(Spain)
YOHEI FURUMOTO, AKIHIRO ARAKI, SAYURI NITTA, HIROKO NAGATA, KENTO TAKENAKA, KOUHEI SUZUKI, ERIKO OKADA, TAKAO HORIUCHI, MAMORU WATANABE. Report of successful rescue of disrupted capsafter rule endoscopy retention. Asian Pacific Digestive Week 2017.09.26 Hongkong
Takenaka K, Ohtsuka K, Kitazume Y, Matsuoka K, Fujii T, Nagahori M, Kimura M, Watanabe M. Magnetic resonance enterography for small bowel mucosal healing in patients with Crohn’s disease. APDW2017 2017.09.23 (Hong Kong)
Motobayashi M, Matsuoka K, Iwamoto F, Takenaka K, Fujii T, Nagahori M, Enomoto N, Ohtsuka K, Watanabe M. Correlation of Fecal Calprotectin Levels with Endoscopic Severity Evaluated with Balloon-assisted Endoscopy in Patients with Crohn’s Disease. . AOCC2017 2017.06.17 Seoul, Korea
Fujii T, Kitazume Y, Takenaka K, Kimura M, Matsuoka K, Nagahori M, Ohtsuka K, Watanabe M. The 5-point MR enterocolonography classification based on endoscopic findings for activity assessment of Crohn's disease. AOCC2017 2017.06.16 Seoul (Korea)
Takenaka K, Ohtsuka K, Kitazume Y, Matsuoka K, Fujii T, Nagahori M, Kimura M, Watanabe M. Magnetic resonance evaluation for small bowel endoscopic remission in patients with crohn’s disease. AOCC2017 2017.06.15 Seoul (Korea)
Nibe Y, Oshima S, Aonuma E, Matsuda H, Otsubo K, Maeyashiki C, Kobayashia M, Matsuzawa Y , Nakada S, Watanabe M. Novel polyubiquitin imaging reveals that atypical polyubiquitin contribute to autophagy. GI research Academy 2017 2017.06.09 Tokyo (JAPAN)
Takenaka K, Ohtsuka K, Watanabe M. Magnetic resonance evaluation for small bowel strictures of Crohn’s disease: comparison with balloon enteroscopy. APDW2016 2016.11.05 Kobe convention center, KOBE(JAPAN)
Fujii T, Takenaka K, Kitazume Y, Kimura M, Matsuoka K, Nagahori M, Ohtsuka K, Watanabe M. MR enterocolonography can detect small bowel strictures and predict surgery in patients with Crohn’s disease: Comparison with balloon enteroscopy. APDW2016 2016.11.03 Kobe convention center, KOBE(JAPAN)
Toshimitsu Fujii, Kento Takenaka, Maiko Kimura, Katsuyoshi Matsuoka, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe. MR enterocolonography evaluation for small bowel strictures in patients with Crohn’s disease: comparison with balloon enteroscopy. UEGW2016 2016.10.18 Vienna(Austria)
Ohtsuka K, Takenaka K, Fujii T, Matsuoka K, Nagahori M, Kimura M, Fukuda M, Katsukura N, Watanabe M. Mucosal healing improves prognosis of endoscopic balloon dilatatiion for small intestinal strictures of Crohn's disease. AOCC2016 2016.07.09 Kyoto
Toshimitsu Fujii, Kento Takenaka, Maiko Kimura, Katsuyoshi Matsuoka, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe. The evaluation for small bowel strictures on MR enterocolonography in patients with Crohn’s disease. AOCC2016 2016.07.08 Kyoto International Conference Center, Kyoto(JAPAN)
Kento Takenaka, Kazuo Ohtsuka, Yoshio Kitazume, Masakazu Nagahori, Katsuyoshi Matsuoka, Toshimitsu Fujii, Maiko Kimura, Tomoyuki Fujioka, Mamoru Watanabe. Enteroscopic and MR findings of small bowel in Crohn’s disease. AOCC2016 2016.07.07 Kyoto International Conference Center, Kyoto(JAPAN)
Maiko Kimura, Katsuyoshi Matsuoka, Eiko Saito, Toshimitsu Fujii, Kento Takenaka, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe. Salvage therapy for corticosteroid-refractory ulcerative colitis patients.. AOCC2016 2016.07.07 Kyoto International Conference Center, Kyoto(JAPAN)
Kazuo Ohtsuka, Kento Takenaka, Toshimitsu Fujii, Katsuyoshi Matsuoka, Masakazu Nagahori, Maiko Kimura, Masayoshi Fukuda, Nobuhiro Katsukura, Mamoru Watanabe. Mucosal healing improves prognosis of endoscopic balloon dilatation for small intestinal strictures of Crohn’s disease. AOCC2016 2016.07.07 Kyoto
Kazuo Ohtsuka, Kento Takenaka, Toshimitsu Fujii, Katsuyoshi Matsuoka, Masakazu Nagahori, Kengo Nozaki, Masayoshi Fukuda, Mamoru Watanabe. Mucosal Healing is imoietant for better outcomes of endosdopic balloon dilatation for smakk intestinal stricture of crohn's disease. DDW2016 2016.05.23 San Diego
Kentaro Takenaka, Kazuo Ohtsuka, Yoshio Kitazume, Masakazu Nagahori, Katsuyoshi Matsuoka, Toshimitsu Fujii, Maiko Kimura, Tomoyuki Fujioka Mamoru Watanabe. Magnetic resonance evaluation for deep small intestinal strictures in patients with Crohn’s disease. 第102回日本消化器病学会総会_The 5th International Forum 2016.04.21 京王プラザホテル(東京都新宿区)
Takenaka K, Ohtsuka K, Kitazume Y, Nagahori M, Matsuoka K, Fujii T, Kimura M, Fujioka T, Watanabe M. Enteroscopic and MR findings of small intestine in Crohn’s disease.. 7th APTC 2016.04.20 京王プラザホテル(東京都新宿区)
K. Matsuoka, E. Saito, T. Fujii, K. Takenaka, F. Iwamoto, M. Kimura, M. Nagahori, K. Ohtsuka, M. Watanabe. Efficacy and safety of sequential rescue therapy with infliximab and tacrolimus in patients with corticosteroid-refractory Ulcerative Colitis. 11th Congress of ECCO - European Crohn‘s and Colitis Organisation 2016.03.19 Amsterdam(Nederland)
Fujii T,Takenaka K,Kitazume Y,Saito E,Matsuoka K,Nagahori M,Ohtsuka K,Watanabe M.. Modifying and validating endoscopic and magnetic resonance scoring systems for the deep small intestine in Crohn’s disease.. AOCC2015 2015.06.19 Beijing
Toshimitsu Fujii, Kento Takenaka, Eiko Saito, Katsuyoshi Matsuoka, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe. Modifying and Validating Endoscopic and Magnetic Resonance Scoring Systems for the Deep Small Intestine in Crohn's Disease. DDW 2015 2015.05.17 Washington, D.C.
Matsuoka K, Saito E, Fujii T, Takenaka K, Nagahori M, Ohtsuka K, Watanabe M. The Ulcerative Colitis Endscopic Index of Severity (UCEIS) is useful to evaluate endoscopic improvement and to predict medium-term prognosis in Ulcerative Colitis patients treated with tacrolimus. 10th Congress of ECCO - Inflammatory Bowel Diseases 2015 2015.02.20 Barcelona
Fujii T, Naganuma M, Kitazume Y, Takenaka K, Nagahori M, Saito E, Ohtsuka K, Watanabe M. MR enterocolonography can identify patients who need additional treatment by predicting recurrence, hospitalization and surgey of Crohn's disease patients in remission. UEGW2014 2014.10.20 Vienna
Takenaka K, Ohtsuka K, Kitazume Y, Nagahori M, Fujii T, Saito E, Watanabe M. Magnetic resonance enterocolonography can detect small intestinal active lesions in crohn's disease;comparison with balloon enteroscopy. UEGW2014 2014.10.20 Vienna
Takenaka K, Otsuka K, Nagahori M, Fujii T, Saito E, Watanabe M. Comparison of Magnetic Resonance and Balloon Enteroscopic Examination of Deep Small Intestine in Patients with Crohn's Disease. The 2nd Annual Meeting of AOCC 2014.06.20 Seoul
Takenaka K, Otsuka K, Nagahori M, Fujii T, Saito E, Watanabe M. Comparing MR enterocolonography to enteroscopy in Crohn's disease, especially focusing on small intestinal findings. 9th congress of European Crohn's and Colitis Organisation 2014.02.20 Copenhagen
Fujii T, Naganuma M, Saito E, Nagahori M, Watanabe M. Intravenous tacrolimus therapy can rapidly induce remission in refractory ulcerative colitis. DDW2012 2012.05.19 San Diego
Real world experience with tofacitinib in refractory ulcerative colitis.. 2020.02.07